PrescriptionDrugs.org

What to Expect When Starting Lisinopril

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

Introduction

Lisinopril (brand names Prinivil, Zestril) is an angiotensin-converting enzyme (ACE) inhibitor and one of the most commonly prescribed medications in the United States, with tens of millions of prescriptions dispensed annually [1][2]. It is FDA-approved for hypertension, heart failure, and improving survival after acute myocardial infarction [1]. ACE inhibitors also provide renal protection in patients with diabetic nephropathy, slowing the progression of kidney disease [2][5].

Lisinopril works by blocking the ACE enzyme that converts angiotensin I to angiotensin II, a potent vasoconstrictor. By reducing angiotensin II levels, blood vessels relax, blood volume decreases, and blood pressure falls [2]. The medication begins lowering blood pressure within 1-2 hours of the first dose, with peak effect at approximately 6-7 hours [1]. However, reaching optimal, stable blood pressure control typically takes 2-4 weeks of consistent dosing [1][5].

The 2017 ACC/AHA hypertension guidelines recommend ACE inhibitors as first-line therapy for hypertension, particularly in patients with diabetes, chronic kidney disease, or heart failure [3]. This guide covers what to expect when starting lisinopril, including the well-known ACE inhibitor dry cough — a class-specific side effect caused by bradykinin accumulation that affects approximately 5-20% of patients [2][4]. Understanding the adjustment timeline can help you manage early side effects and stay committed to this proven cardiovascular medication.

Week-by-week timeline

Day 1-3First-dose dizziness is most common in patients on diuretics, those who are salt-restricted, or those who are dehydrated [1]. Rise slowly from sitting or lying positions. If you feel very dizzy or faint, sit or lie down immediately and contact your provider. Severe first-dose hypotension is uncommon in euvolemic patients [2].

First Doses

Lisinopril begins lowering blood pressure within 1-2 hours of your first dose, with peak effect at approximately 6-7 hours [1]. Most patients start at 5-10 mg daily (2.5-5 mg if on concurrent diuretics, if elderly, or if volume-depleted) [1][5]. Your cardiovascular system is adjusting to the sudden vasodilation, and your body's compensatory mechanisms (baroreceptor reflexes) need time to recalibrate. First-dose hypotension is a well-characterized phenomenon with ACE inhibitors, particularly in patients who are sodium-depleted, dehydrated, or already on diuretics [1][2].

  • Dizziness or lightheadedness when standing (orthostatic hypotension), especially prominent in the first 24-48 hours
  • Mild headache (~5% incidence in trials)
  • Fatigue or drowsiness as blood pressure adjusts
  • First-dose hypotension (more pronounced if dehydrated, sodium-restricted, or on diuretics)
Week 1-2The ACE inhibitor dry cough affects approximately 5-20% of patients and is caused by bradykinin accumulation, not an allergy [2][4][6]. While not dangerous, it can be very bothersome. Report it to your provider — it is the most common reason patients switch from ACE inhibitors to ARBs.

Early Adjustment

Your cardiovascular system is adapting to the new, lower blood pressure baseline. Dizziness typically improves within 3-7 days as baroreceptor reflexes recalibrate [2]. Your provider may ask you to monitor blood pressure at home during this period. The ACE inhibitor cough, if it develops, typically appears within the first 1-4 weeks of treatment — it is a dry, persistent, tickling cough unrelated to respiratory infection [4][6]. A meta-analysis found the cough incidence to be approximately 10% overall, with higher rates (up to 20%) in women and East Asian patients [6].

  • Dizziness improving as cardiovascular adaptation occurs
  • Possible onset of dry, nonproductive cough (the hallmark ACE inhibitor side effect)
  • Mild fatigue diminishing
  • Occasional mild headache
  • Blood pressure beginning to trend toward target range
Week 3-4If serum creatinine rises >30% from baseline or potassium exceeds 5.5 mEq/L, your provider will reassess the dose or consider alternative therapy [1][5]. These lab checks are a routine safety measure for all ACE inhibitors.

Dose Adjustment

Your provider will check blood pressure and renal function (serum creatinine and potassium) at 2-4 weeks [1][3]. A small initial rise in serum creatinine (up to 30% from baseline) is expected and acceptable with ACE inhibitors — it reflects the hemodynamic effect on the kidney and is generally not a reason to stop the medication [5]. The dose may be increased (typical range 10-40 mg daily) if blood pressure has not reached the target of <130/80 mmHg per current ACC/AHA guidelines [3]. Blood pressure should be trending downward consistently.

  • Blood pressure noticeably lower — home readings trending toward target
  • Most patients feeling well-adjusted to the medication
  • Dry cough, if present, typically established by this point (does not worsen with time)
  • Improved energy as cardiovascular system benefits from optimized blood pressure
  • Potassium and kidney function being monitored
Month 2-3If the dry cough is intolerable (it does not resolve with continued use), your provider can switch you to an ARB (such as losartan or valsartan), which works on the same renin-angiotensin system without causing cough [3][6]. ARBs are considered therapeutically equivalent for most indications.

Stable Blood Pressure Control

Full blood pressure-lowering effect is typically achieved within 2-4 weeks at the target dose [1]. Your provider will confirm stable kidney function and potassium levels. For most patients, lisinopril becomes a straightforward once-daily medication with minimal ongoing side effects. The cardiovascular benefits extend well beyond blood pressure reduction: the HOPE trial demonstrated that ACE inhibitors reduced the risk of myocardial infarction by 20%, stroke by 32%, and cardiovascular death by 26% in high-risk patients [7]. Long-term adherence is critical to realizing these benefits [3].

  • Stable blood pressure at or near target range (<130/80 mmHg)
  • No ongoing symptoms for most patients
  • Dry cough has either resolved spontaneously (rare) or persists — persistent cough may prompt a switch to an ARB
  • Kidney-protective and heart-protective benefits accumulating over time
  • Medication well-integrated into daily routine

When to call your doctor

Contact your healthcare provider if you experience:

  • Swelling of the face, lips, tongue, or throat (angioedema) — this is a rare (~0.1-0.7%) but potentially life-threatening emergency that requires immediate medical attention; it is more common in Black patients and can occur at any time during therapy [1][2][4]
  • Difficulty breathing or swallowing, especially if accompanied by facial swelling [1]
  • Fainting or severe dizziness upon standing — may indicate excessive blood pressure reduction requiring dose adjustment [1]
  • Significantly decreased urine output — may indicate acute kidney injury, especially if combined with dehydration, NSAIDs, or other nephrotoxic agents [1]
  • Signs of hyperkalemia: muscle weakness, slow or irregular heartbeat, tingling or numbness, fatigue — serum potassium >5.5 mEq/L requires prompt evaluation [1][2]
  • You become pregnant or plan to become pregnant — ACE inhibitors are contraindicated in pregnancy due to risk of fetal renal damage, oligohydramnios, and other birth defects (FDA Pregnancy Category D for 2nd/3rd trimester) [1][3]
  • Persistent dry cough that disrupts sleep or daily activities — while not dangerous, it may warrant switching to an ARB [4][6]
  • Signs of infection: sore throat, fever, unusual bruising — very rarely, ACE inhibitors can cause neutropenia [1]

Tips for getting started

Take lisinopril at the same time each day — many providers and patients prefer bedtime dosing, as the first-dose dizziness effect is mitigated by sleeping through the initial blood pressure reduction [1][2]. However, morning dosing is equally acceptable, and some research suggests that bedtime dosing of antihypertensives may provide superior cardiovascular protection [5]. Consistency matters more than the specific time.

Stay well hydrated, especially in hot weather, during exercise, or if you have GI illness with vomiting or diarrhea. Dehydration amplifies the blood-pressure-lowering effect of ACE inhibitors and increases the risk of hypotension and acute kidney injury [1]. Rise slowly from sitting or lying positions during the first few days of treatment — orthostatic hypotension (a sudden drop in blood pressure when standing) is most common in the first 1-2 weeks and in patients who are volume-depleted [1][2].

Avoid potassium supplements and potassium-rich salt substitutes (such as Morton Lite Salt) unless specifically directed by your provider [1]. ACE inhibitors reduce aldosterone-mediated potassium excretion, which can raise serum potassium levels. Hyperkalemia (potassium >5.5 mEq/L) occurred in approximately 2-4% of patients in clinical trials and is the most clinically important metabolic side effect [1][4]. Your provider will check potassium levels at baseline and after dose adjustments.

If you develop a persistent, dry, tickling cough — the most recognizable ACE inhibitor side effect — do not stop the medication on your own. This cough is caused by bradykinin accumulation in the lungs (ACE normally breaks down bradykinin) and affects approximately 5-20% of patients, with higher rates in women and Asian populations [2][4][6]. Report it to your provider, who can assess whether switching to an ARB (such as losartan or valsartan), which provides similar benefits without the cough, is appropriate [3][6]. Limit alcohol intake, which can enhance the blood-pressure-lowering effect and worsen dizziness [1].

Frequently asked questions

More about Lisinopril

Lisinopril drug guideSide effects, dosage, interactions, and moreLisinopril vs LosartanCompare these medicationsLisinopril vs RamiprilCompare these medicationsAmlodipine vs LisinoprilCompare these medicationsLisinopril & LosartanInteraction detailsLisinopril & MetforminInteraction detailsLisinopril & SpironolactoneInteraction details

References

  1. [Regulatory] Lisinopril (Prinivil/Zestril) FDA Prescribing Information. Merck. Revised 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/019777s075lbl.pdf Accessed 2025-01-15.
  2. [Regulatory] Lisinopril. StatPearls [Internet]. National Library of Medicine. Updated 2024. https://www.ncbi.nlm.nih.gov/books/NBK482230/ Accessed 2025-01-15.
  3. [Regulatory] Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Hypertension. 2018;71(6):e13-e115. https://pubmed.ncbi.nlm.nih.gov/29133356/ Accessed 2025-01-15.
  4. [Clinical] Dicpinigaitis PV. Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1):169S-173S. https://pubmed.ncbi.nlm.nih.gov/23076923/ Accessed 2025-01-15.
  5. [Clinical] Messerli FH, Bangalore S, Bavishi C, Rimoldi SF. Angiotensin-converting enzyme inhibitors in hypertension: to use or not to use? J Am Coll Cardiol. 2018;71(13):1474-1482. https://pubmed.ncbi.nlm.nih.gov/32413243/ Accessed 2025-01-15.
  6. [Clinical] Bangalore S, Kumar S, Messerli FH. Angiotensin-converting enzyme inhibitor associated cough: deceptive information from the Physicians Desk Reference. Am J Med. 2010;123(11):1016-1030. https://pubmed.ncbi.nlm.nih.gov/20813395/ Accessed 2025-01-15.
  7. [Clinical] Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients (HOPE study). N Engl J Med. 2000;342(3):145-153. https://pubmed.ncbi.nlm.nih.gov/10639539/ Accessed 2025-01-15.
  8. [Clinical] ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358(15):1547-1559. https://pubmed.ncbi.nlm.nih.gov/18997196/ Accessed 2025-01-15.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: